Literature DB >> 8171280

Helicobacter pylori-associated gastritis and dyspepsia. The influence on migrating motor complexes.

N Qvist1, L Rasmussen, C K Axelsson.   

Abstract

Twenty-five patients with dyspepsia were included. In 19 patients with a median age of 48 (range, 20-72) years endoscopy and histologic examination of biopsy specimens from the antrum and corpus of the stomach showed Helicobacter pylori-positive gastritis as the only pathologic finding. In six patients with a median age of 42 (range, 32-56) years H. pylori-negative gastritis was found. After an overnight fast the patients underwent an ambulatory duodenal motility study for 6-8 h. Twenty-five young healthy men served as the control group. In patients with H. pylori-positive gastritis the duration of phase I of the migrating motor complex (MMC) was significantly shorter than in the control group. The median value was 33 min (quartiles, 24-49), and in controls 56 min (40-136 min). Phase II was of significantly longer duration, with a median value of 88 min (51-121 min) in the patient group and 39 min (22-89 min) in the control group. The duration of phase III and the whole MMC cycle was similar in the two groups. However, in the patients with H. pylori-negative gastritis the values of the duration of the different phases of the MMC were similar to those of the patients with H. pylori-positive gastritis. Nine patients were reexamined after eradication of the H. pylori infection, and the motility pattern had changed to the characteristics found in normals. In conclusion, the patients with dyspepsia and gastritis showed a disturbed motility pattern. The disturbance was similar whether there was colonization of H. pylori or not.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8171280     DOI: 10.3109/00365529409090451

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Impaired postprandial gastric myoelectrical activity in Chinese patients with nonulcer dyspepsia.

Authors:  C L Lu; C Y Chen; F Y Chang; L J Kang; S D Lee; H C Wu; T S Kuo
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

Review 2.  Helicobacter pylori eradication in patients with non-ulcer dyspepsia.

Authors:  H H Xia; N J Talley
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

3.  A patient with impaired gastric motility.

Authors:  P A Paine; W Rees; C Babbs; J L Shaffer; G Armstrong; H Burnett; Q Aziz
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 4.  Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?

Authors:  J Labenz; P Malfertheiner
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

5.  Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy.

Authors:  N E Gulcelik; E Kaya; B Demirbas; C Culha; G Koc; M Ozkaya; E Cakal; R Serter; Y Aral
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

6.  Association between H. pylori, duodenal mechanosensory thresholds, and small intestinal motility in chronic unexplained dyspepsia.

Authors:  G Holtmann; N J Talley; H Goebell
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

7.  Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication.

Authors:  John M Moschos; George Kouklakis; Stergios Vradelis; Petros Zezos; Michael Pitiakoudis; Dimitrios Chatzopoulos; Christos Zavos; Jannis Kountouras
Journal:  Ann Gastroenterol       Date:  2014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.